Daclatasvir (DCV)
Sponsors
Bristol-Myers Squibb
Conditions
Chronic Hepatitis C InfectionHepatitis C Virus
Phase 3
Phase III Hallmark DUAL: ASV+DCV (Nulls/Partials, Intolerants/Ineligibles. Naives)
CompletedNCT01581203
Start: 2012-05-31End: 2014-09-30Updated: 2015-10-09
Efficacy and Safety Study of Pegylated Interferon Lambda-1a With Ribavirin and Daclatasvir, to Treat naïve Subjects With Chronic HCV Genotypes 1, 2, 3, and 4 Who Are Co-infected With HIV
TerminatedNCT01866930
Start: 2013-07-11End: 2015-08-27Updated: 2023-06-13